CTNNB1 and hepatocellular carcinoma: However, CTNNB1 mutations, a major driver of WNT activation, were highly prevalent in both groups (31.9% H/L vs. 32.4% NHW, p = 1), indicating that β-catenin pathway activation is a shared oncogenic feature of HCC across ethnicities.